News
Ganesan Vaidyanathan, Ph.D., Receives Grant from National Cancer Institute
Ganesan Vaidyanathan, Ph.D., was awarded an R01 Grant from the National Cancer Institute at the National Institutes of Health, for developing a Nanobody-based PET imaging agent to assess the HER2 status in breast cancer patients.